The Chicago Entrepreneur

Merck sold $3.2 billion of its Covid oral antiviral treatment, driving first-quarter revenue growth

Merck soundly beat Wall Street estimates for its top and bottom lines, reporting earnings of $2.14 per share on $15.9 billion in revenue.

Previous post Robinhood shares fall as retail brokerage reports shrinking revenue, fewer active users
Next post Comcast shares slump as broadband subscriber growth continues to slow